We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

Dr. Wolfgang Kircher

Counsel
Munich

Dr. Wolfgang Kircher

Wolfgang Kircher is a transaction lawyer and clients' trusted corporate law advisor. He has extensive experience in the structuring, negotiation and implementation of joint ventures, business acquisitions and disposals and also counsels on group-internal business transformations, cash pools and enterprise agreements creating fiscal unities.

Wolfgang has also advised on the equity and debt financing aspects of a multitude of his clients' transactions. Wolfgang's industry focus is 'old economy', ranging from mining and manufacturing of specialty materials to agriculture.

As a result of his secondments to New York and to a German financial institution, Wolfgang gained broad experience in transactions with a U.S. angle and in the restructuring of debt financings.

Representative Experience

Advising AMG Mining AG on an equity investment by Alterna Capital Partners, a share capital increase and a domination and profit and loss pooling agreement.

Advising BayWa Aktiengesellschaft in the acquisition of PC Agrar group, the "smart farming" software provider.

Advising various groups of companies in relation to centralized cash management of the national and international group companies.

Advising a group of companies on activities in Africa, such as a joint venture, equity and debt financing by the shareholders and a credit facility by a development bank.

Advising a group of companies on internal (solvent) restructuring transactions under the German Business Transformation Act.

Education and admissions

Memberships

  • Delegate, American Chamber of Commerce in Germany
  • German Banking Law Association
  • German-American Lawyers' Association (DAJV)

Latest thinking and events

Published Works

Risks Associated With the Takeover of Pharmaceutical Companies

Transkript
View More
Loading data